Ved Srivastava
Fondatore presso Phoundry Pharmaceuticals, Inc.
Profilo
Ved Srivastava is the founder of Phoundry Pharmaceuticals, Inc. which was founded in 2015.
Currently, he is the President-Elect at American Peptide Society, Inc. Dr. Srivastava has worked as a Principal at Amylin Pharmaceuticals, Inc. and Psylin Neurosciences, Inc. He has also worked as Vice President-Research Production at New England Peptide, Inc. Dr. Srivastava holds a doctorate degree from the University of Lucknow.
Posizioni attive di Ved Srivastava
| Società | Posizione | Inizio |
|---|---|---|
Phoundry Pharmaceuticals, Inc.
 Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Phoundry Pharmaceuticals, Inc. engages in the discovery of peptide therapeutic drugs for metabolic diseases. The firm also provides drugs for diabetes and obesity diseases. The company was founded by Paul L. Feldman, Andrew Young, Ved Srivastava, Mark Paulik, James Way and Shane Roller in 2015 and is headquartered in Research Triangle Park, NC. | Fondatore | 01/01/2015 |
American Peptide Society, Inc.
 American Peptide Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Peptide Society, Inc. operates as scientific and educational organization which provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. The company was founded in 1990 and is headquartered in London, the United Kingdom. | Presidente | - |
Precedenti posizioni note di Ved Srivastava
| Società | Posizione | Fine |
|---|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Psylin Neurosciences, Inc.
 Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Psylin Neurosciences, Inc. discovers and develops peptide hormones for the treatment of psychiatric disorders. The firm is formed in partnership between Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. The company was founded on January 30, 2007 and is located in San Diego, CA | Corporate Officer/Principal | - |
New England Peptide, Inc.
 New England Peptide, Inc. Chemicals: Major DiversifiedProcess Industries New England Peptide, Inc. designs and manufactures peptides, polyclonal antibodies, and monoclonal antibodies for drug and vaccine discovery organizations. Its products include TrypTides, bioactive peptides, amino acids and resins, peptide synthesis accessories, ME Kit Exosome isolation, SISCAPA assay reagents, and TrypRaws. The company was founded by Samuel A. Massoni and Jennifer L. Massoni in 1998 and is headquartered in Gardner, MA. | Corporate Officer/Principal | - |
Formazione di Ved Srivastava
| University of Lucknow | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Psylin Neurosciences, Inc.
Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Psylin Neurosciences, Inc. discovers and develops peptide hormones for the treatment of psychiatric disorders. The firm is formed in partnership between Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. The company was founded on January 30, 2007 and is located in San Diego, CA | Health Technology |
New England Peptide, Inc.
New England Peptide, Inc. Chemicals: Major DiversifiedProcess Industries New England Peptide, Inc. designs and manufactures peptides, polyclonal antibodies, and monoclonal antibodies for drug and vaccine discovery organizations. Its products include TrypTides, bioactive peptides, amino acids and resins, peptide synthesis accessories, ME Kit Exosome isolation, SISCAPA assay reagents, and TrypRaws. The company was founded by Samuel A. Massoni and Jennifer L. Massoni in 1998 and is headquartered in Gardner, MA. | Process Industries |
American Peptide Society, Inc.
American Peptide Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Peptide Society, Inc. operates as scientific and educational organization which provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. The company was founded in 1990 and is headquartered in London, the United Kingdom. | Commercial Services |
Phoundry Pharmaceuticals, Inc.
Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Phoundry Pharmaceuticals, Inc. engages in the discovery of peptide therapeutic drugs for metabolic diseases. The firm also provides drugs for diabetes and obesity diseases. The company was founded by Paul L. Feldman, Andrew Young, Ved Srivastava, Mark Paulik, James Way and Shane Roller in 2015 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Borsa valori
- Insiders
- Ved Srivastava
